发明名称 |
MIR-33 INHIBITORS AND USES THEREOF |
摘要 |
<p>The miRNA miR-33 is shown to inhibit the expression of carnitine O-octaniltransferase (CROT), Carnitine palmitoyltransferase 1A (CPT1a) and hydroxyacyl-CoA-dehydrogenase (HADHB), reduce fatty acid oxidation in hepatic cells, and target the insulin receptor substrate 2 (IRS-2) independent of its ability to elevating plasma high density lipoprotein (HDL) levels. MiR-33 inhibitors are also shown to increase cholesterol efflux from peripheral cells, such as cholesterol-laden macrophages present in atherosclerotic plaques. Compositions and methods are therefore provided for treating or preventing metabolic syndrome and atherosclerosis using miR-33 inhibitors. The miR-33 inhibitors are preferably antagomirs having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions.</p> |
申请公布号 |
EP2609199(A1) |
申请公布日期 |
2013.07.03 |
申请号 |
EP20110758294 |
申请日期 |
2011.08.26 |
申请人 |
NEW YORK UNIVERSITY |
发明人 |
FERNANDEZ-HERNANDO, CARLOS;MOORE, KATHRYN, J.;SUAREZ, YAJAIRA;RAYNER, KATEY, J. |
分类号 |
C12N15/113;A61K31/712 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|